...
首页> 外文期刊>Einstein (So Paulo) >Treatment of breast cancer patients from a public healthcare system in a private center: costs of care for a pilot public-private partnership in oncology
【24h】

Treatment of breast cancer patients from a public healthcare system in a private center: costs of care for a pilot public-private partnership in oncology

机译:私人中心的公共医疗系统对乳腺癌患者的治疗:肿瘤学试点公私合营项目的护理费用

获取原文
           

摘要

OBJECTIVE: To describe the flow and costs associated with the diagnosis and treatment of patients with breast cancer who come from the public healthcare system and were treated at Hospital Israelita Albert Einstein. METHODS: Between August 2009, and December 2011, 51 patients referred by the Unified Public Healthcare System (SUS) had access to Hospital Israelita Albert Einstein for diagnostic radiology, medical oncology, radiotherapy, and oncologic/breast reconstruction surgery. The data were collected retrospectively from the hospital records, patient charts, pharmacy records, and from the hospital billing system. RESULTS: The total sum spent for diagnosis and treatment of these 51 patients was US$ 1,457,500.00. This value encompassed expenses with a total of 85 hospitalizations, 2,875 outpatient visits, 16 emergency room visits, and all expenses associated with these stays at the hospital. The expenditure for treatment of each patient submitted to biopsy, breast conserving surgery, adjuvant chemotherapy without trastuzumab (a regime with taxane followed by anthracycline), radiotherapy, and 5 years of tamoxifen was approximately US$ 25,500.00. CONCLUSION: Strategies for cost-reduction of treatment in the private setting are necessary to enable future large-scale public-private partnerships in oncology.
机译:目的:描述来自公共医疗保健系统并在Israelta Albert Einstein医院接受治疗的乳腺癌患者的诊断和治疗相关流程和费用。方法:在2009年8月至2011年12月之间,由统一公共医疗保健系统(SUS)推荐的51名患者可以进入以色列艾伯塔·爱因斯坦医院进行放射诊断,医学肿瘤学,放射治疗以及肿瘤/乳房再造手术。数据是从医院记录,患者病历,药房记录和医院计费系统中回顾性收集的。结果:这51例患者的诊断和治疗总费用为1,457,500.00美元。该值包括总共85例住院,2875例门诊,16例急诊室就诊以及与这些住院相关的所有费用。每位接受活检,保乳手术,无曲妥珠单抗辅助化疗(紫杉烷加蒽环类药物治疗),放疗和5年他莫昔芬治疗的患者的支出约为25,500.00美元。结论:在私立环境中降低治疗成本的策略对于实现未来大规模的肿瘤学公私合作伙伴关系是必要的。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号